Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

β-estradiol slows hair growth in mice.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

JAK inhibitors show promise in treating difficult skin diseases.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Certain Chinese herbs may help treat kidney fibrosis by targeting TGF-β.

The glucocorticoid receptor helps protect skin from tumors and other issues.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.